Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBHC
3901
DELISTED
The Brand House Collective
TBHC
| $165K | ﹤0.01% |
130,660
-3,532
| -3% | -$5.14K |
|
3902
Asia Pacific Wire & Cable
APWC
$64.7M
| $164K | ﹤0.01% |
107,599
| – | – |
|
3903
Vivos Therapeutics
VVOS
$4.5M
| $163K | ﹤0.01% |
57,349
+12,522
| +28% | +$49.2K |
|
|
AFCG
3904
AFC Gamma
AFCG
$63.4M
| $163K | ﹤0.01% |
29,219
+4,467
| +18% | +$35.5K |
|
3905
Network-1 Technologies
NTIP
$36.4M
| $163K | ﹤0.01% |
125,346
+11,896
| +10% | +$16.3K |
|
3906
Rallybio
RLYB
$85.8M
| $162K | ﹤0.01% |
30,944
-34
| -0.1% | -$215 |
|
|
PLMK
3907
Plum Acquisition Corp IV
PLMK
$256M
| $161K | ﹤0.01% |
+16,059
| New | +$161K |
|
3908
P3 Health Partners
PIII
$38.5M
| $161K | ﹤0.01% |
19,608
+647
| +3% | +$6.38K |
|
|
ENZ
3909
DELISTED
Enzo Biochem, Inc.
ENZ
| $160K | ﹤0.01% |
431,042
+63,949
| +17% | +$35.3K |
|
3910
Focus Universal
FCUV
$3.65M
| $159K | ﹤0.01% |
956
+257
| +37% | +$51.8K |
|
3911
Gray Media Inc
GTN.A
$604M
| $159K | ﹤0.01% |
20,141
+2,627
| +15% | +$18.8K |
|
|
FATBB
3912
DELISTED
FAT Brands
FATBB
| $159K | ﹤0.01% |
60,053
-12,927
| -18% | -$44.3K |
|
|
TOYO
3913
TOYO Co
TOYO
$248M
| $159K | ﹤0.01% |
53,111
-6,861
| -11% | -$21.5K |
|
3914
Radcom
RDCM
$169M
| $156K | ﹤0.01% |
13,668
| – | – |
|
3915
Nephros
NEPH
$45.7M
| $155K | ﹤0.01% |
90,289
+5,439
| +6% | +$8.53K |
|
3916
Cognition Therapeutics
CGTX
$96.7M
| $155K | ﹤0.01% |
368,961
+16,613
| +5% | +$9.76K |
|
3917
Armata Pharmaceuticals
ARMP
$173M
| $155K | ﹤0.01% |
105,837
-952
| -0.9% | -$1.9K |
|
|
INTZ
3918
Intrusion
INTZ
$17.3M
| $154K | ﹤0.01% |
137,690
+69,028
| +101% | +$114K |
|
|
USAR
3919
USA Rare Earth Inc
USAR
$4.73B
| $153K | ﹤0.01% |
25,745
| – | – |
|
3920
Intensity Therapeutics
INTS
$11.2M
| $153K | ﹤0.01% |
3,099
+525
| +20% | +$29.2K |
|
3921
Creative Realities
CREX
$39.6M
| $152K | ﹤0.01% |
77,696
+36
| +0% | +$83 |
|
|
MYSE
3922
Myseum.AI Inc
MYSE
$13.1M
| $151K | ﹤0.01% |
39,214
+14,529
| +59% | +$46K |
|
3923
Imunon
IMNN
$6.77M
| $151K | ﹤0.01% |
10,997
+302
| +3% | +$3.62K |
|
3924
Natural Alternatives International
NAII
$14.9M
| $150K | ﹤0.01% |
43,633
-1,429
| -3% | -$5.71K |
|
|
PTN
3925
Palatin Technologies
PTN
$13.8M
| $150K | ﹤0.01% |
5,151
+1,340
| +35% | +$62.4K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.